| scholarly article | Q13442814 |
| P50 | author | Rithwik Ramachandran | Q59388016 |
| P2093 | author name string | Roland Kaufmann | |
| Peter Henklein | |||
| Frank D Böhmer | |||
| Karl-Jürgen Halbhuber | |||
| Morley D Hollenberg | |||
| Utz Settmacher | |||
| Annett Eitner | |||
| Mahmoud Saifeddine | |||
| Kathrin Katenkamp | |||
| Martin Westermann | |||
| Reimar Krieg | |||
| Antje Horn | |||
| Claudia Oettel | |||
| P2860 | cites work | Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells | Q40559771 |
| Protease-activated receptor 2 in colon cancer: trypsin-induced MAPK phosphorylation and cell proliferation are mediated by epidermal growth factor receptor transactivation | Q40580473 | ||
| MAP kinase-mediated proliferation of DLD-1 carcinoma by the stimulation of protease-activated receptor 2 | Q40631207 | ||
| Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin | Q43559301 | ||
| cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization | Q48214623 | ||
| 2-furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. | Q51026666 | ||
| Proteinase-activated receptors, targets for kallikrein signaling | Q24298638 | ||
| Protease-activated receptor 3 is a second thrombin receptor in humans | Q24310957 | ||
| Cloning and characterization of human protease-activated receptor 4 | Q24322941 | ||
| Thrombin receptor overexpression in malignant and physiological invasion processes | Q24323035 | ||
| Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation | Q24337851 | ||
| Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides | Q24530304 | ||
| Molecular cloning of a potential proteinase activated receptor | Q24563694 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| Targeting the c-Met signaling pathway in cancer | Q28246393 | ||
| The Met tyrosine kinase receptor in development and cancer | Q28263626 | ||
| A dual thrombin receptor system for platelet activation | Q28280578 | ||
| The emerging roles of human tissue kallikreins in cancer | Q28290701 | ||
| Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. | Q30909624 | ||
| N,N-Dialkylaminostyryl dyes: specific and highly fluorescent substrates of peroxidase and their application in histochemistry | Q33308786 | ||
| Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration | Q33723243 | ||
| A key role for transmembrane prolines in calcitonin receptor-like receptor agonist binding and signalling: implications for family B G-protein-coupled receptors. | Q34379110 | ||
| Mechanisms of desensitization and resensitization of proteinase-activated receptor-2. | Q34388721 | ||
| Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells | Q34473395 | ||
| 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage | Q34686193 | ||
| Protease-activated receptors: contribution to physiology and disease | Q35715253 | ||
| Aberrant Expression and Activation of the Thrombin Receptor Protease-Activated Receptor-1 Induces Cell Proliferation and Motility in Human Colon Cancer Cells | Q35749110 | ||
| Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. | Q36028984 | ||
| Inhibition of tissue factor signaling suppresses tumor growth | Q36384586 | ||
| Dysregulation of growth factor signaling in human hepatocellular carcinoma. | Q36519010 | ||
| New therapies for hepatocellular carcinoma. | Q36519041 | ||
| ERK MAP kinase in G cell cycle progression and cancer | Q36519437 | ||
| Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2. | Q36565261 | ||
| Proteinase-activated receptor-2 (PAR2): a tumor suppressor in skin carcinogenesis | Q40137788 | ||
| Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. | Q40166523 | ||
| Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells | Q40333102 | ||
| Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. | Q40503317 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 1487-1496 | |
| P577 | publication date | 2009-06-22 | |
| P1433 | published in | Carcinogenesis | Q326022 |
| P1476 | title | Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion | |
| P478 | volume | 30 |
| Q47329058 | Evaluation of antibodies directed against human protease-activated receptor-2. |
| Q37193598 | Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling |
| Q46588142 | Factor VII-Induced MicroRNA-135a Inhibits Autophagy and Is Associated with Poor Prognosis in Hepatocellular Carcinoma |
| Q54517201 | Kallikrein-related peptidase signaling in colon carcinoma cells: targeting proteinase-activated receptors. |
| Q33955272 | Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis |
| Q37421226 | Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein |
| Q34364217 | Peritumoral small ephrinA5 isoform level predicts the postoperative survival in hepatocellular carcinoma |
| Q34148307 | Pharmacology, biodistribution, and efficacy of GPCR-based pepducins in disease models. |
| Q38934450 | Protease-activated receptor 2 agonist increases cell proliferation and invasion of human pancreatic cancer cells |
| Q36322931 | Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis. |
| Q28079318 | Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer |
| Q47118943 | Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling. |
| Q35396873 | Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation |
| Q54490877 | Proteinase-activated receptor 2 (PAR(2)) in cholangiocarcinoma (CCA) cells: effects on signaling and cellular level. |
| Q37138893 | Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo |
| Q39540197 | Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5. |
| Q54120113 | Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. |
| Q33761497 | Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells |
| Q37348262 | Proteinase-activated receptors (PARs) - focus on receptor-receptor-interactions and their physiological and pathophysiological impact |
| Q55690940 | Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer. |
| Q39160971 | TF/FVIIa/PAR2 promotes cell proliferation and migration via PKCα and ERK-dependent c-Jun/AP-1 pathway in colon cancer cell line SW620. |
| Q27024397 | Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug development |
Search more.